Sichenzia Ross Ference LLP Represents Avinger Inc. in Close of $5.2 Million Underwritten Public Offering of Common Stock
Press Release – New York, NY – August 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Avinger, Inc. (NASDAQ: “AVGR”), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), in a closing of an underwritten public offering of 11,063,830 shares of its common stock at a price of $0.47 per share. The offering was made pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC).
Aegis Capital Corp. acted as sole bookrunner for the offering.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, Avital Perlman, and Barrett DiPaolo and associate Jacob Tabman.
- Sichenzia Ross Ference Partner Andrew M. J. Bernstein, Esq. to Present Grand Jury CLE for Lawline - September 20, 2020
- Founding Partner Gregory Sichenzia Quoted in Bankrate Article Discussing Prominent IPOs to Keep an Eye On - September 15, 2020
- Sichenzia Ross Ference LLP Represents Vuzix in $15.5 Million Registered Direct Offering - September 10, 2020